Infinity Development Holdings Company Limited (0640.HK)
Macau, MO
Infinity Development Holdings Company Limited, an investment holding firm, primarily focuses on the production and distribution of various adhesive products. These include primers, hardeners, and specialized adhesives for vulcanized shoes, which are supplied to footwear manufacturers in major markets like the People's Republic of China, Vietnam, Indonesia, and Bangladesh. Beyond manufacturing, the company is actively involved in trading raw materials and adhesives, as well as offering a range of other chemical products for industrial applications. Its operations also extend to providing agency and administrative support services, alongside the processing and packaging of its adhesive offerings. Established in 1987, the company is headquartered in Macau. It was previously known as Infinity Chemical Holdings Company Limited before rebranding to its current name in February 2016. Infinity Development Holdings Company Limited operates as a subsidiary of All Reach Investments Limited.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.78% | +0.39% | +1.99% | -3.40% | -2.29% | +0.00% | +20.75% | +75.34% | +100.00% | +28.00% | +37.63% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-04 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | +1 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+13.4% ★ Q1'26: +20.8% (vs Q1'24)
-
EPS growth Chemicals - Specialty: +13.2%+19.4% ★ Q1'26: +9.9% (vs Q1'24)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+11.3% Q1'26: +26.3% (vs Q1'24)
-
EBIT margin Chemicals - Specialty: +8.8%+16.5% ★ Q1'26: +14.4% (vs Q1'24)
-
ROIC Chemicals - Specialty: +5.6%+35.6% ★ Q1'26: +64.0% (vs Q1'24)
-
Share dilution Chemicals - Specialty: +0.1%+0.0% Q1'26: +8.1% (vs Q1'24)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×0.05× ★ Q1'26: 0.02× (vs Q1'24)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Sep 2026 1 Rev. Ana. 1 EPS Ana. |
Sep 2027 1 Rev. Ana. 1 EPS Ana. |
Sep 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|
| Revenue |
869.41M
869.41M – 869.41M
|
917.89M
917.89M – 917.89M
+5.6% YoY
|
977.00M
977.00M – 977.00M
+6.4% YoY
|
| EBITDA |
132.18M
132.18M – 132.18M
|
139.55M
139.55M – 139.55M
+5.6% YoY
|
148.54M
148.54M – 148.54M
+6.4% YoY
|
| EBIT |
114.69M
114.69M – 114.69M
|
121.08M
121.08M – 121.08M
+5.6% YoY
|
128.88M
128.88M – 128.88M
+6.4% YoY
|
| Net Income |
78.59M
78.59M – 78.59M
|
97.46M
97.46M – 97.46M
+24.0% YoY
|
113.23M
113.23M – 113.23M
+16.2% YoY
|
| SGA |
174.64M
174.64M – 174.64M
|
184.38M
184.38M – 184.38M
+5.6% YoY
|
196.25M
196.25M – 196.25M
+6.4% YoY
|
| EPS |
0.28
0.28 – 0.28
|
0.35
0.35 – 0.35
+24.0% YoY
|
0.40
0.40 – 0.40
+16.2% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-28 | A+ | 5/5 | 5/5 | 5/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-27 | A+ | 5/5 | 5/5 | 5/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-26 | A+ | 5/5 | 5/5 | 5/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-22 | A+ | 5/5 | 5/5 | 5/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-21 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-20 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-19 | A+ | 5/5 | 5/5 | 5/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-18 | A+ | 5/5 | 5/5 | 5/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-15 | A+ | 5/5 | 5/5 | 5/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-14 | A+ | 5/5 | 5/5 | 5/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-13 | A+ | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-12 | A+ | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-11 | A+ | 5/5 | 5/5 | 5/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-08 | A+ | 5/5 | 5/5 | 5/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-07 | A+ | 5/5 | 5/5 | 5/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-06 | A+ | 5/5 | 5/5 | 5/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-05 | A+ | 5/5 | 5/5 | 5/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-04-29 | A+ | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-28 | A+ | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-27 | A+ | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-22 | A | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-21 | A | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-20 | A | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-17 | A | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-15 | A | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Un Ieong | Founder, Executive Chairman & Chief Executive Officer | 16M | male |
| Ka Lun Ip | Deputy GM & Executive Director | 5M | male |
| Stephen Graham Prince | Director of Business & Marketing and Executive Director | 3M | male |
| Guo Liang Zheng | Deputy GM and Production & Operation Director | — | male |
| Ta-Liang Lai | Financial Controller & Executive Officer | — | male |
| Kong Wang Chan | Company Secretary | — | male |
| Xuan Feng Zhong | Director of Human Resources & Information Technology Departments | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 0640.HK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
